Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS) Abnormal Uterine Bleeding Safety Study

Clinical trial NCT07580560 · COMPLETED

Trial details

NCT number: NCT07580560
Sponsor: Aqua Therapeutics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Uterine Hemorrhage

Start date: 2024-11-28
Primary completion: 2025-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.